Q2 Korean Biotech Roundup: Partners Return Multiple Assets

U-Turns For OliX, Artiva, Voronoi

 
• By Jung Won Shin
  
deal break
Korean Biotech Sector Lacks Major Positive News In Q2 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia